Bioreagents

IgG/IgM Depleted Human Complement

IgG/IgM Depleted Human Complement

IgG/IgM Depleted Human Serum Heat-Inactivated

IgG/IgM Depleted Human Serum Heat-Inactivated

IgG/IgM Depleted Human Serum Heat-Inactivated

IgG/IgM Depleted Human Serum Heat-Inactivated

Mouse IgG1 (K) purified from clarified mouse MOPC 21 ascites using multi-step procedures which may include salt fractionation, gel filtration, ion-exchange chromatography, affinity chromatography and immunoabsorption. The product is dialyzed into 0.02 M TRIS, 0.15 M sodium chloride, pH 8.1, filtered through a 0.22 µm filter and vialed.

[MOPC 21]
Ascites fluid, collected from Balb/c mice which carry plasmacytomas subcutaneously, are clarified by centrifugation and filtration. It is dialyzed, adjusted to yield at least 5 mg of immunoglobulin, then vialed and lyophilized. Clarified ascites are tested for immunoglobulin by immunoelectrophoresis using antisera specific for the particular type and isotype. Approximately 10% of the total protein is immunoglobulin (including trace levels of the host’s immunoglobulins), 80% is albumin, and 10% is complement and other proteins.

From myeloma source, reactive against IgG1 by subclass-specific radial immunodiffusion and ELISA. This product contains 1% IgG2 , IgG3 , and IgG4 .

From myeloma source, reactive against IgG1 by subclass-specific radial immunodiffusion and ELISA. This product contains 1% IgG2 , IgG3 , and IgG4 .

From myeloma source, this product is reactive specific to its subclass by subclass-specific radial immunodiffusion and ELISA. It contains % IgG1 , IgG3 , and IgG4 .

IgG2A (Kappa) UPC 10, mouse myeloma, purified

Mouse IgG2b is purified from clarified mouse MOPC 141 ascites using multi-step procedures which may include salt fractionation, gel filtration, ion-exchange chromatography, affinity chromatography, and immunoabsorption. The product is dialyzed into 0.02 M Tris 0.15M sodium chloride, pH 8.1, filtered through a 0.22 µm filter and vialed.

Mouse IgG2b (j) is purified from clarified mouse MOPC 195 ascites using multi-step procedures which may include salt fractionation, gel filtration, ion-exchange chromatography, affinity chromatography and immunoabsorption. The product is dialyzed into 0.02 M Tris, 0.15 M sodium chloride, pH 8.1, filtered through a 0.22 µm filter and vialed.

Lyophilized Clarified mouse myeloma ascites IgG2b (j) MOPC 195.

Mouse IgG3 (k) is purified from clarified mouse FLOPC 21 ascites using multi-step procedures which may include salt fractionation, gel filtration, ion-exchange chromatography, affinity chromatography and immunoabsorption. The product is dialyzed into 0.02 M Tris, 0.15 M sodium chloride, pH 8.1, filtered through a 0.22 µm filter and vialed.

[MOPC 104E]
These myeloma proteins are purified from ascites by a combination of salt precipitation, ion exchange and bioaffinity chromatography. Purified proteins are dialyzed into 0.02M Tris, 0.14M sodium chloride, pH 8.1. Product is adjusted to 1.0 mg/ml, filtered, vialed, and stored frozen at -70°C. Product is shipped on dry ice.

Imatinib mesylate, NeuroPure

Imatinib mesylate, NeuroPure

IMDM, 1000 mL

IMDM, 500 mL

IMDM, 6 X 500 mL

IMDM,1000 mL

IMDM,2 X 5 L

IMDM,500 mL

IMETIT

Imidazole, ≥99%

Imidazole, ≥99%

Imidazole

Imidazole

Imidazole

Imidazole

Imidazole is a histamine antagonist.

Imidazole is a histamine antagonist.

Imidazole is a histamine antagonist.

Imidazolidinyl Urea

Imidazolidinyl Urea

Imidazolidinyl Urea

Imiquimod, NeuroPure

Imiquimod, NeuroPure

Immuno-Fluore™ Mounting Medium is a mounting medium for immunofluorescence preparations. A stabilizing agent has been added that inhibits the fading of fluorescence under the influence of ultraviolet light.

Close-fitting covers to minimize gel dehydration. Recessed bottom to prevent scratching on the bench surface. Plate is hydrophilic

IMMUNOGLOBULINS POLYCLONAL ANTIBODY

Indigo Carmine

Indigo Carmine

Indigo Carmine

Indinavir Sulfate, NeuroPure

Indinavir Sulfate, NeuroPure

Indirubin-3′-Oxime, NeuroPure

Indirubin-3′-Oxime, NeuroPure